Cargando…
Pharmacokinetics and Generic Drug Switching: A Regulator’s View
There appears to be a mismatch between the assumed therapeutic equivalence of generic drugs, their interchangeability, and reported clinical discomfort following generic drug use and drug switches. In this article, we describe why we are of the opinion that the current regulatory approach to the eva...
Autores principales: | Glerum, Pieter J., Neef, Cees, Burger, David M., Yu, Yang, Maliepaard, Marc |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7467961/ https://www.ncbi.nlm.nih.gov/pubmed/32557345 http://dx.doi.org/10.1007/s40262-020-00909-8 |
Ejemplares similares
-
Interchangeability of Generic Drugs: A Nonparametric Pharmacokinetic Model of Gabapentin Generic Drugs
por: Glerum, Pieter J., et al.
Publicado: (2018) -
Drug switching in the Netherlands: a cohort study of 20 active substances
por: Glerum, Pieter J., et al.
Publicado: (2020) -
Investigation into the interchangeability of generic formulations using immunosuppressants and a broad selection of medicines
por: Yu, Yang, et al.
Publicado: (2015) -
Drug Repurposing of Generic Drugs: Challenges and the Potential Role for Government
por: van der Pol, Karel H., et al.
Publicado: (2023) -
Quantification of Adverse Drug Reactions Related to Drug Switches in The Netherlands
por: Glerum, Pieter J., et al.
Publicado: (2020)